Net Income for Insulet (PODD)
According to Insulet's latest reported financial statements, the company's current net income (TTM) is $247.10M USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
PODD
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$247.10M
YoY change
-40.9%
5Y CAGR
+105.2%
Peak year (2024)
$418.30M
Cumulative net income
$197.09M
Net Income history chart for Insulet (PODD) from 2002 to 2025
Net Income history table for Insulet (PODD) from 2002 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $247.10M | -40.9% | ||
| 2024 | $418.30M | +102.8% | ||
| 2023 | $206.30M | +4384.8% | ||
| 2022 | $4.60M | -72.6% | ||
| 2021 | $16.80M | +147.1% | ||
| 2020 | $6.80M | -41.4% | ||
| 2019 | $11.60M | +252.4% | ||
| 2018 | $3.29M | -112.3% | ||
| 2017 | -$26.83M | -7.1% | ||
| 2016 | -$28.88M | -60.7% | ||
| 2015 | -$73.52M | +42.8% | ||
| 2014 | -$51.50M | +14.5% | ||
| 2013 | -$44.97M | -13.3% | ||
| 2012 | -$51.87M | -9.3% | ||
| 2011 | -$57.17M | -6.5% | ||
| 2010 | -$61.16M | -23.1% | ||
| 2009 | -$79.54M | -14.3% | ||
| 2008 | -$92.79M | +73.3% | ||
| 2007 | -$53.54M | +48.9% | ||
| 2006 | -$35.95M | +66.2% | ||
| 2005 | -$21.64M | +56.5% | ||
| 2004 | -$13.82M | +15.7% | ||
| 2003 | -$11.94M | -5.1% | ||
| 2002 | -$12.58M | — |
Net Income values are taken from Insulet's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Insulet (PODD) most recent annual net income stands at $247.10M (2025) – plunged 40.9% year-over-year.
Over 2020–2025 (5 years), Insulet net income expanded at a +105.2% compound annual rate, with the latest reading among the more recent periods of the dataset.
Insulet net income peaked at $418.30M in 2024; the latest annual figure is $247.10M in 2025 (40.9% below peak).
The highest annual net income of $418.30M was reported in 2024. The lowest in the available history was -$92.79M in 2008.
Insulet (PODD) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $15.15B.
Insulet Net Income by Year
Insulet Net Income 2025: $247.10M
Insulet net income in 2025 was $247.10M, plunged 40.9% below 2024.
Insulet Net Income 2024: $418.30M
Insulet net income in 2024 was $418.30M, surged 102.8% from 2023. This figure represents the highest annual value in the available history.
Insulet Net Income 2023: $206.30M
Insulet net income in 2023 was $206.30M, surged 4384.8% from 2022.
Insulet Net Income 2022: $4.60M
Insulet net income in 2022 was $4.60M, plunged 72.6% below 2021.
Insulet Net Income 2021: $16.80M
Insulet net income in 2021 was $16.80M.
See more financial history for Insulet (PODD).
Sector peers — Net Income
Companies in the same sector as Insulet, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is Insulet's net income?
- Latest reported net income for Insulet (PODD) is $247.10M (period ending December 31, 2025).
How has Insulet net income changed year-over-year?
- Insulet (PODD) net income changed -40.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Insulet net income?
- Insulet (PODD) net income compound annual growth rate is +105.2% over the most recent 5 years available.
When did Insulet net income hit its highest annual value?
- Insulet net income reached its highest annual value of $418.30M in 2024.
What was Insulet net income in 2024?
- Insulet (PODD) net income in 2024 was $418.30M.
What was Insulet net income in 2025?
- Insulet (PODD) net income in 2025 was $247.10M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
PODD Overview
Company profile, financial tools, and key metrics
PODD Revenue Counter
Earns $85.88 every second. See per minute, hour, and day.
PODD Earnings Counter
Earns $7.84 per second net profit. See per minute, hour, and day.
PODD Economic Scale
Exceeds St. Lucia's GDP. Compare with world economies.
PODD What If Invested
What if you had invested $1,000? See historical returns from any date.
PODD How It Makes Money
Discover visual breakdown of $2.71B in revenue — where it comes from and where it goes.
PODD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PODD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PODD Daily Price Character
Explosive · 51.5% historical win rate (green days). Streaks & record days.
PODD Buybacks
0.30% TTM buyback yield. Shareholder yield & SBC comparison.